Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats (2006)
- Authors:
- Ferreira-Melo, Silvia Elaine - Universidade Estadual de Campinas (UNICAMP)
- Yugar-Toledo, Juan Carlos - Universidade Estadual de Campinas (UNICAMP)
- Coelho, Otávio Rizzi - Universidade Estadual de Campinas (UNICAMP)
- De Luca, Iara M. - Universidade Estadual de Campinas (UNICAMP)
- Tanus-Santos, José Eduardo
- Hyslop, Stephen - Universidade Estadual de Campinas (UNICAMP)
- Irigoyen, Maria Cláudia
- Moreno Júnior, Heitor - Universidade Estadual de Campinas (UNICAMP)
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejphar.2006.04.039
- Subjects: ENDOTÉLIO VASCULAR; HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 542, p. 141-147, 2006
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERREIRA-MELO, Silvia Elaine et al. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. European Journal of Pharmacology, v. 542, p. 141-147, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2006.04.039. Acesso em: 16 abr. 2024. -
APA
Ferreira-Melo, S. E., Yugar-Toledo, J. C., Coelho, O. R., De Luca, I. M., Tanus-Santos, J. E., Hyslop, S., et al. (2006). Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. European Journal of Pharmacology, 542, 141-147. doi:10.1016/j.ejphar.2006.04.039 -
NLM
Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno Júnior H. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats [Internet]. European Journal of Pharmacology. 2006 ; 542 141-147.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.ejphar.2006.04.039 -
Vancouver
Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno Júnior H. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats [Internet]. European Journal of Pharmacology. 2006 ; 542 141-147.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1016/j.ejphar.2006.04.039 - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1016/j.ejphar.2006.04.039 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
